Tag: Prescription Drugs
Antithymocyte Globulin Cuts Loss of β-Cell Function in Type 1 Diabetes
ATG 2.5 and 0.5 mg/kg reduces loss of β-cell function in young people with recent-onset type 1 diabetes
FDA Approves Opzelura for Atopic Dermatitis in Children
It is the first topical JAK inhibitor approved in the U.S. for pediatric atopic dermatitis
Oral Semaglutide Effective for Weight Loss in Overweight or Obesity
Estimated mean change in body weight from baseline to week 64 was −13.6 and −2.2 percent with oral semaglutide and placebo, respectively
FDA Grants Accelerated Approval for First Treatment for Barth Syndrome
Forzinity helps improve strength of muscle to straighten the leg and works by improving mitochondria structure and function
FDA Approves Subcutaneous Tremfya Induction Treatment for Ulcerative Colitis
Efficacy and safety found to be similar to intravenous induction
Declines Seen in New, Additional Prescribing of Opioids in Patients With Cancer
New opioid prescribing was stable for patients with metastatic cancer with pain and declined for those reporting no pain
High Exposure to Prenatal Prescribed Opioid Analgesics Likely Not Associated With ASD Risk
Associations were largely or fully attenuated using designs other than accounting for measured confounders and in sibling comparisons
Half Discontinue Semaglutide for Weight Loss Within One Year
Factors tied to discontinuation included younger age, male sex, socioeconomic deprivation, higher comorbidity level
Methotrexate Cuts Systolic BP in Rheumatoid Arthritis
No significant differences seen in diastolic blood pressure, augmentation index, DAS28-CRP
Potentially Inappropriate Medications Linked to Frailty at Cancer Diagnosis
Each additional Geriatric Oncology-PIM linked to 66 percent increase in odds of being mildly, moderate-to-severely frail at diagnosis
